Suzuki K - Search Results

1

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS. Kadota K, et al. Among authors: suzuki k. Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30. Ann Surg Oncol. 2012. PMID: 22644511 Free PMC article.

2

Surgeons and simulators.

Colovos C, Suzuki K, Leitman IM, Adusumilli PS. Colovos C, et al. Among authors: suzuki k. Natl Med J India. 2009 Nov-Dec;22(6):323-4. Natl Med J India. 2009. PMID: 20384025 No abstract available.

3

Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.

Suzuki K, Servais EL, Rizk NP, Solomon SB, Sima CS, Park BJ, Kachala SS, Zlobinsky M, Rusch VW, Adusumilli PS. Suzuki K, et al. J Thorac Oncol. 2011 Apr;6(4):762-7. doi: 10.1097/JTO.0b013e31820d614f. J Thorac Oncol. 2011. PMID: 21325982 Free article.

4

Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.

Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Kadota K, et al. Among authors: suzuki k. J Thorac Oncol. 2011 May;6(5):896-904. doi: 10.1097/JTO.0b013e318211127a. J Thorac Oncol. 2011. PMID: 21358344 Free article. Clinical Trial.

5

Prognostic immune markers in non-small cell lung cancer.

Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS. Suzuki K, et al. Clin Cancer Res. 2011 Aug 15;17(16):5247-56. doi: 10.1158/1078-0432.CCR-10-2805. Epub 2011 Jun 9. Clin Cancer Res. 2011. PMID: 21659461 Review.

6

Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.

Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS. Suzuki K, et al. Cancer Immunol Immunother. 2011 Dec;60(12):1721-8. doi: 10.1007/s00262-011-1073-8. Epub 2011 Jul 19. Cancer Immunol Immunother. 2011. PMID: 21769693 Free PMC article.

7

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS. Bograd AJ, et al. Among authors: suzuki k. Cancer Immunol Immunother. 2011 Nov;60(11):1509-27. doi: 10.1007/s00262-011-1103-6. Epub 2011 Sep 13. Cancer Immunol Immunother. 2011. PMID: 21913025 Free PMC article. Review.

8

A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.

Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS. Kadota K, et al. Among authors: suzuki k. Mod Pathol. 2012 Feb;25(2):260-71. doi: 10.1038/modpathol.2011.146. Epub 2011 Oct 7. Mod Pathol. 2012. PMID: 21983936 Free PMC article.

9

An in vivo platform for tumor biomarker assessment.

Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. Servais EL, et al. Among authors: suzuki k. PLoS One. 2011;6(10):e26722. doi: 10.1371/journal.pone.0026722. Epub 2011 Oct 26. PLoS One. 2011. PMID: 22046338 Free PMC article.

10

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Kadota K, et al. Among authors: suzuki k. Mod Pathol. 2012 Aug;25(8):1117-27. doi: 10.1038/modpathol.2012.58. Epub 2012 Apr 13. Mod Pathol. 2012. PMID: 22499226 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,190 results

Search Page